Interstitial Nephritis in a Patient with Inflammatory Bowel Disease

Tubulointerstitial nephritis in patients with inflammatory bowel disease has been linked to the use of 5-ASA derivatives. Various aspects of this theory have been challenged with a potential role for the underlying autoimmune disorder. Steroids are the mainstay of treatment and mycophenolate mofetil...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasanth, Payaswini, Parmley, Michelle, Torrealba, Jose, Hamdi, Tamim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039298/
https://www.ncbi.nlm.nih.gov/pubmed/27703822
http://dx.doi.org/10.1155/2016/4260365
_version_ 1782456023271866368
author Vasanth, Payaswini
Parmley, Michelle
Torrealba, Jose
Hamdi, Tamim
author_facet Vasanth, Payaswini
Parmley, Michelle
Torrealba, Jose
Hamdi, Tamim
author_sort Vasanth, Payaswini
collection PubMed
description Tubulointerstitial nephritis in patients with inflammatory bowel disease has been linked to the use of 5-ASA derivatives. Various aspects of this theory have been challenged with a potential role for the underlying autoimmune disorder. Steroids are the mainstay of treatment and mycophenolate mofetil might be an effective alternative. We report a patient who responded well to mycophenolate despite continuing mesalamine, the suspected offending agent.
format Online
Article
Text
id pubmed-5039298
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-50392982016-10-04 Interstitial Nephritis in a Patient with Inflammatory Bowel Disease Vasanth, Payaswini Parmley, Michelle Torrealba, Jose Hamdi, Tamim Case Rep Nephrol Case Report Tubulointerstitial nephritis in patients with inflammatory bowel disease has been linked to the use of 5-ASA derivatives. Various aspects of this theory have been challenged with a potential role for the underlying autoimmune disorder. Steroids are the mainstay of treatment and mycophenolate mofetil might be an effective alternative. We report a patient who responded well to mycophenolate despite continuing mesalamine, the suspected offending agent. Hindawi Publishing Corporation 2016 2016-09-14 /pmc/articles/PMC5039298/ /pubmed/27703822 http://dx.doi.org/10.1155/2016/4260365 Text en Copyright © 2016 Payaswini Vasanth et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Vasanth, Payaswini
Parmley, Michelle
Torrealba, Jose
Hamdi, Tamim
Interstitial Nephritis in a Patient with Inflammatory Bowel Disease
title Interstitial Nephritis in a Patient with Inflammatory Bowel Disease
title_full Interstitial Nephritis in a Patient with Inflammatory Bowel Disease
title_fullStr Interstitial Nephritis in a Patient with Inflammatory Bowel Disease
title_full_unstemmed Interstitial Nephritis in a Patient with Inflammatory Bowel Disease
title_short Interstitial Nephritis in a Patient with Inflammatory Bowel Disease
title_sort interstitial nephritis in a patient with inflammatory bowel disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039298/
https://www.ncbi.nlm.nih.gov/pubmed/27703822
http://dx.doi.org/10.1155/2016/4260365
work_keys_str_mv AT vasanthpayaswini interstitialnephritisinapatientwithinflammatoryboweldisease
AT parmleymichelle interstitialnephritisinapatientwithinflammatoryboweldisease
AT torrealbajose interstitialnephritisinapatientwithinflammatoryboweldisease
AT hamditamim interstitialnephritisinapatientwithinflammatoryboweldisease

Ejemplares similares